254 related articles for article (PubMed ID: 33789297)
1. The Two Formyl Peptide Receptors Differently Regulate GPR84-Mediated Neutrophil NADPH Oxidase Activity.
Mårtensson J; Sundqvist M; Manandhar A; Ieremias L; Zhang L; Ulven T; Xie X; Björkman L; Forsman H
J Innate Immun; 2021; 13(4):242-256. PubMed ID: 33789297
[TBL] [Abstract][Full Text] [Related]
2. GRK2 selectively attenuates the neutrophil NADPH-oxidase response triggered by β-arrestin recruiting GPR84 agonists.
Fredriksson J; Holdfeldt A; Mårtensson J; Björkman L; Møller TC; Müllers E; Dahlgren C; Sundqvist M; Forsman H
Biochim Biophys Acta Mol Cell Res; 2022 Jul; 1869(7):119262. PubMed ID: 35341806
[TBL] [Abstract][Full Text] [Related]
3. Barbadin selectively modulates FPR2-mediated neutrophil functions independent of receptor endocytosis.
Sundqvist M; Holdfeldt A; Wright SC; Møller TC; Siaw E; Jennbacken K; Franzyk H; Bouvier M; Dahlgren C; Forsman H
Biochim Biophys Acta Mol Cell Res; 2020 Dec; 1867(12):118849. PubMed ID: 32916203
[TBL] [Abstract][Full Text] [Related]
4. FPR2 signaling without β-arrestin recruitment alters the functional repertoire of neutrophils.
Gabl M; Holdfeldt A; Sundqvist M; Lomei J; Dahlgren C; Forsman H
Biochem Pharmacol; 2017 Dec; 145():114-122. PubMed ID: 28855087
[TBL] [Abstract][Full Text] [Related]
5. A pepducin derived from the third intracellular loop of FPR2 is a partial agonist for direct activation of this receptor in neutrophils but a full agonist for cross-talk triggered reactivation of FPR2.
Gabl M; Winther M; Skovbakke SL; Bylund J; Dahlgren C; Forsman H
PLoS One; 2014; 9(10):e109516. PubMed ID: 25303226
[TBL] [Abstract][Full Text] [Related]
6. Function and regulation of GPR84 in human neutrophils.
Forsman H; Dahlgren C; Mårtensson J; Björkman L; Sundqvist M
Br J Pharmacol; 2024 May; 181(10):1536-1549. PubMed ID: 36869866
[TBL] [Abstract][Full Text] [Related]
7. Functional selective FPR1 signaling in favor of an activation of the neutrophil superoxide generating NOX2 complex.
Lind S; Dahlgren C; Holmdahl R; Olofsson P; Forsman H
J Leukoc Biol; 2021 Jun; 109(6):1105-1120. PubMed ID: 33040403
[TBL] [Abstract][Full Text] [Related]
8.
Sundqvist M; Christenson K; Gabl M; Holdfeldt A; Jennbacken K; Møller TC; Dahlgren C; Forsman H
J Immunol; 2019 Dec; 203(12):3349-3360. PubMed ID: 31694908
[TBL] [Abstract][Full Text] [Related]
9. The Lipidated Peptidomimetic Lau-((S)-Aoc)-(Lys-βNphe)6-NH2 Is a Novel Formyl Peptide Receptor 2 Agonist That Activates Both Human and Mouse Neutrophil NADPH Oxidase.
Holdfeldt A; Skovbakke SL; Winther M; Gabl M; Nielsen C; Perez-Gassol I; Larsen CJ; Wang JM; Karlsson A; Dahlgren C; Forsman H; Franzyk H
J Biol Chem; 2016 Sep; 291(38):19888-99. PubMed ID: 27422818
[TBL] [Abstract][Full Text] [Related]
10. Gastrin-releasing peptide/neuromedin B receptor antagonists PD176252, PD168368, and related analogs are potent agonists of human formyl-peptide receptors.
Schepetkin IA; Kirpotina LN; Khlebnikov AI; Jutila MA; Quinn MT
Mol Pharmacol; 2011 Jan; 79(1):77-90. PubMed ID: 20943772
[TBL] [Abstract][Full Text] [Related]
11. Stable formyl peptide receptor agonists that activate the neutrophil NADPH-oxidase identified through screening of a compound library.
Forsman H; Kalderén C; Nordin A; Nordling E; Jensen AJ; Dahlgren C
Biochem Pharmacol; 2011 Feb; 81(3):402-11. PubMed ID: 21095183
[TBL] [Abstract][Full Text] [Related]
12. A pepducin designed to modulate P2Y2R function interacts with FPR2 in human neutrophils and transfers ATP to an NADPH-oxidase-activating ligand through a receptor cross-talk mechanism.
Gabl M; Holdfeldt A; Winther M; Oprea T; Bylund J; Dahlgren C; Forsman H
Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1228-37. PubMed ID: 26996596
[TBL] [Abstract][Full Text] [Related]
13. The PAR4-derived pepducin P4Pal
Holdfeldt A; Lind S; Hesse C; Dahlgren C; Forsman H
Biochem Pharmacol; 2020 Oct; 180():114143. PubMed ID: 32653592
[TBL] [Abstract][Full Text] [Related]
14. Functional and signaling characterization of the neutrophil FPR2 selective agonist Act-389949.
Lind S; Sundqvist M; Holmdahl R; Dahlgren C; Forsman H; Olofsson P
Biochem Pharmacol; 2019 Aug; 166():163-173. PubMed ID: 31085160
[TBL] [Abstract][Full Text] [Related]
15. Structural Determinants in the
Viklund M; Fredriksson J; Holdfeldt A; Lind S; Franzyk H; Dahlgren C; Sundqvist M; Forsman H
J Immunol; 2022 Apr; 208(7):1632-1641. PubMed ID: 35321878
[TBL] [Abstract][Full Text] [Related]
16. Reactivation of Gαi-coupled formyl peptide receptors is inhibited by Gαq-selective inhibitors when induced by signals generated by the platelet-activating factor receptor.
Holdfeldt A; Dahlstrand Rudin A; Gabl M; Rajabkhani Z; König GM; Kostenis E; Dahlgren C; Forsman H
J Leukoc Biol; 2017 Sep; 102(3):871-880. PubMed ID: 28760822
[TBL] [Abstract][Full Text] [Related]
17. Identification of C-terminal phosphorylation sites of N-formyl peptide receptor-1 (FPR1) in human blood neutrophils.
Maaty WS; Lord CI; Gripentrog JM; Riesselman M; Keren-Aviram G; Liu T; Dratz EA; Bothner B; Jesaitis AJ
J Biol Chem; 2013 Sep; 288(38):27042-27058. PubMed ID: 23873933
[TBL] [Abstract][Full Text] [Related]
18. Honokiol suppresses formyl peptide-induced human neutrophil activation by blocking formyl peptide receptor 1.
Liu FC; Yu HP; Syu YT; Fang JY; Lin CF; Chang SH; Lee YT; Hwang TL
Sci Rep; 2017 Jul; 7(1):6718. PubMed ID: 28751674
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Inflammation and Oxidative Stress by Formyl Peptide Receptors in Cardiovascular Disease Progression.
Caso VM; Manzo V; Pecchillo Cimmino T; Conti V; Caso P; Esposito G; Russo V; Filippelli A; Ammendola R; Cattaneo F
Life (Basel); 2021 Mar; 11(3):. PubMed ID: 33804219
[TBL] [Abstract][Full Text] [Related]
20. Formyl peptide derived lipopeptides disclose differences between the receptors in mouse and men and call the pepducin concept in question.
Winther M; Holdfeldt A; Sundqvist M; Rajabkhani Z; Gabl M; Bylund J; Dahlgren C; Forsman H
PLoS One; 2017; 12(9):e0185132. PubMed ID: 28934373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
